why choose us

First received: May 12, 2023

Clinical Trial: A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hemophilia A

Study Type: OBSERVATIONAL


Official Title: Prospective, Observational , Multicenter Study of Effectiveness of Efanesoctocog Alfa on Long-term Joint Health in Patients With Hemophilia A

Brief Summary: This is a prospective, observational, multi-center longitudinal cohort study to describe the real-world effectiveness, safety and treatment usage of efanesoctocog alfa in patients with hemophilia A treated per standard of care in the US and Japan.Patients will be enrolled in the study after the introduction of efanesoctocog alfa in the hemophilia treatment landscape in each study country.Decision to initiate treatment with commercially available efanesoctocog alfa will be made by the treating physician…

Read more